Literature DB >> 26175528

Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm From Cardiac Electronic Implanted Devices.

Mintu P Turakhia1, Paul D Ziegler2, Susan K Schmitt2, Yuchiao Chang2, Jun Fan2, Claire T Than2, Edmund K Keung2, Daniel E Singer2.   

Abstract

BACKGROUND: The temporal relationship of atrial fibrillation (AF) and stroke risk is controversial. We evaluated this relationship via a case-crossover analysis of ischemic strokes in a large cohort of patients with cardiac implantable electronic devices. METHODS AND
RESULTS: We identified 9850 patients with cardiac implantable electronic devices remotely monitored in the Veterans Administration Health Care System between 2002 and 2012. There were 187 patients with acute ischemic stroke and continuous heart rhythm monitoring for 120 days before the stroke (age, 69±8.4 years; 98% with an implantable defibrillator). We compared each patient's daily AF burden in the 30 days before stroke (case period) with their AF burden during days 91 to 120 pre stroke (control period). Defining positive AF burden as ≥5.5 hours of AF on any given day, 156 patients (83%) had no positive AF burden in both periods and, in fact, had little to no AF; 15 (8%) patients had positive AF burden in both periods. Among the discordant (informative) patients, 13 exceeded 5.5 hours of AF in the case period but not in the control period, whereas 3 had positive AF burden in the control but not in the case period (warfarin-adjusted odds ratio for stroke, 4.2; 95% confidence interval, 1.5-13.4). Odds ratio for stroke was highest (17.4; 95% confidence interval, 5.39-73.1) in the 5 days immediately after a qualifying occurrence of AF and decreased toward 1.0 as the period after the AF occurrence increased beyond 30 days.
CONCLUSIONS: In this population with continuous heart rhythm recording, multiple hours of AF had a strong but transient effect raising stroke risk.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  United States Department of Veterans Affairs; atrial fibrillation; cross-over studies; defibrillators, implantable; stroke

Mesh:

Year:  2015        PMID: 26175528     DOI: 10.1161/CIRCEP.114.003057

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  48 in total

1.  Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke: A Machine Learning Analysis.

Authors:  Lichy Han; Mariam Askari; Russ B Altman; Susan K Schmitt; Jun Fan; Jason P Bentley; Sanjiv M Narayan; Mintu P Turakhia
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-10-15

Review 2.  Expert opinion paper on atrial fibrillation detection after ischemic stroke.

Authors:  Karl Georg Haeusler; Klaus Gröschel; Martin Köhrmann; Stefan D Anker; Johannes Brachmann; Michael Böhm; Hans-Christoph Diener; Wolfram Doehner; Matthias Endres; Christian Gerloff; Hagen B Huttner; Manfred Kaps; Paulus Kirchhof; Darius Günther Nabavi; Christian H Nolte; Waltraud Pfeilschifter; Burkert Pieske; Sven Poli; Wolf Rüdiger Schäbitz; Götz Thomalla; Roland Veltkamp; Thorsten Steiner; Ulrich Laufs; Joachim Röther; Rolf Wachter; Renate Schnabel
Journal:  Clin Res Cardiol       Date:  2018-04-27       Impact factor: 5.460

Review 3.  Cardioembolic Stroke.

Authors:  Hooman Kamel; Jeff S Healey
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

4.  Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study.

Authors:  Alan S Go; Kristi Reynolds; Jingrong Yang; Nigel Gupta; Judith Lenane; Sue Hee Sung; Teresa N Harrison; Taylor I Liu; Matthew D Solomon
Journal:  JAMA Cardiol       Date:  2018-07-01       Impact factor: 14.676

Review 5.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

6.  Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.

Authors:  Alexander C Perino; Jun Fan; Mariam Askari; Paul A Heidenreich; Edmund Keung; Merritt H Raitt; Jonathan P Piccini; Paul D Ziegler; Mintu P Turakhia
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

7.  Identification of paroxysmal atrial fibrillation subtypes in over 13,000 individuals.

Authors:  Nathan E Wineinger; Paddy M Barrett; Yunyue Zhang; Ikram Irfanullah; Evan D Muse; Steven R Steinhubl; Eric J Topol
Journal:  Heart Rhythm       Date:  2018-08-14       Impact factor: 6.343

8.  Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.

Authors:  Alexander C Perino; Jun Fan; Susan K Schmitt; Mariam Askari; Daniel W Kaiser; Abhishek Deshmukh; Paul A Heidenreich; Christopher Swan; Sanjiv M Narayan; Paul J Wang; Mintu P Turakhia
Journal:  J Am Coll Cardiol       Date:  2017-07-04       Impact factor: 24.094

9.  Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study.

Authors:  Rod Passman; Peter Leong-Sit; Adin-Cristian Andrei; Anna Huskin; Todd T Tomson; Richard Bernstein; Ethan Ellis; Jonathan W Waks; Peter Zimetbaum
Journal:  J Cardiovasc Electrophysiol       Date:  2015-11-23

10.  Cost Effectiveness of Implantable Cardiac Monitor-Guided Intermittent Anticoagulation for Atrial Fibrillation: An Analysis of the REACT.COM Pilot Study.

Authors:  Daniel A Steinhaus; Peter J Zimetbaum; Rod S Passman; Peter Leong-Sit; Matthew R Reynolds
Journal:  J Cardiovasc Electrophysiol       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.